Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Antigen-Specific IFN-γ Responses Correlate with the Activity of M. tuberculosis Infection but Are Not Associated with the Severity of Tuberculosis Disease.

Nikitina IY, Panteleev AV, Sosunova EV, Karpina NL, Bagdasarian TR, Burmistrova IA, Andreevskaya SN, Chernousova LN, Vasilyeva IA, Lyadova IV.

J Immunol Res. 2016;2016:7249369. doi: 10.1155/2016/7249369. Epub 2016 Nov 30.

2.

Antibacterial Effects of Liposomes Containing Phospholipid Cardiolipin and Fluoroquinolone Levofloxacin on Mycobacterium tuberculosis with Extensive Drug Resistance.

Gaidukevich SK, Mikulovich YL, Smirnova TG, Andreevskaya SN, Sorokoumova GM, Chernousova LN, Selishcheva AA, Shvets VI.

Bull Exp Biol Med. 2016 Mar;160(5):675-8. doi: 10.1007/s10517-016-3247-z. Epub 2016 Mar 29.

PMID:
27021087
3.

Mycobacterium tuberculosis Type II Toxin-Antitoxin Systems: Genetic Polymorphisms and Functional Properties and the Possibility of Their Use for Genotyping.

Zaychikova MV, Zakharevich NV, Sagaidak MO, Bogolubova NA, Smirnova TG, Andreevskaya SN, Larionova EE, Alekseeva MG, Chernousova LN, Danilenko VN.

PLoS One. 2015 Dec 14;10(12):e0143682. doi: 10.1371/journal.pone.0143682. eCollection 2015.

4.

Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.

Cegielski JP, Kurbatova E, van der Walt M, Brand J, Ershova J, Tupasi T, Caoili JC, Dalton T, Contreras C, Yagui M, Bayona J, Kvasnovsky C, Leimane V, Kuksa L, Chen MP, Via LE, Hwang SH, Wolfgang M, Volchenkov GV, Somova T, Smith SE, Akksilp S, Wattanaamornkiet W, Kim HJ, Kim CK, Kazennyy BY, Khorosheva T, Kliiman K, Viiklepp P, Jou R, Huang AS, Vasilyeva IA, Demikhova OV; Global PETTS Investigators, Lancaster J, Odendaal R, Diem L, Perez TC, Gler T, Tan K, Bonilla C, Jave O, Asencios L, Yale G, Suarez C, Walker AT, Norvaisha I, Skenders G, Sture I, Riekstina V, Cirule A, Sigman E, Cho SN, Cai Y, Eum S, Lee J, Park S, Jeon D, Shamputa IC, Metchock B, Kuznetsova T, Akksilp R, Sitti W, Inyapong J, Kiryanova EV, Degtyareva I, Nemtsova ES, Levina K, Danilovits M, Kummik T, Lei YC, Huang WL, Erokhin VV, Chernousova LN, Andreevskaya SN, Larionova EE, Smirnova TG.

Clin Infect Dis. 2016 Feb 15;62(4):418-430. doi: 10.1093/cid/civ910. Epub 2015 Oct 27.

5.

Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.

Maslov DA, Zaĭchikova MV, Chernousova LN, Shur KV, Bekker OB, Smirnova TG, Larionova EE, Andreevskaya SN, Zhang Y, Danilenko VN.

Tuberculosis (Edinb). 2015 Sep;95(5):608-12. doi: 10.1016/j.tube.2015.05.013. Epub 2015 Jun 2.

PMID:
26071666
6.

Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides.

Shmalenyuk ER, Chernousova LN, Karpenko IL, Kochetkov SN, Smirnova TG, Andreevskaya SN, Chizhov AO, Efremenkova OV, Alexandrova LA.

Bioorg Med Chem. 2013 Sep 1;21(17):4874-84. doi: 10.1016/j.bmc.2013.07.003. Epub 2013 Jul 11.

PMID:
23891229
7.

Carbocyclic analogues of inosine-5'-monophosphate: synthesis and biological activity.

Matyugina ES, Andreevskaya SN, Smirnova TG, Khandazhinskaya AL.

Acta Naturae. 2012 Oct;4(4):73-7.

8.

Performance of Cepheid ® Xpert MTB/RIF ® and TB-Biochip ® MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis.

Kurbatova EV, Kaminski DA, Erokhin VV, Volchenkov GV, Andreevskaya SN, Chernousova LN, Demikhova OV, Ershova JV, Kaunetis NV, Kuznetsova TA, Larionova EE, Smirnova TG, Somova TR, Vasilieva IA, Vorobieva AV, Zolkina SS, Cegielski JP.

Eur J Clin Microbiol Infect Dis. 2013 Jun;32(6):735-43. doi: 10.1007/s10096-012-1798-0. Epub 2012 Dec 22.

9.

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.

Dalton T, Cegielski P, Akksilp S, Asencios L, Campos Caoili J, Cho SN, Erokhin VV, Ershova J, Gler MT, Kazennyy BY, Kim HJ, Kliiman K, Kurbatova E, Kvasnovsky C, Leimane V, van der Walt M, Via LE, Volchenkov GV, Yagui MA, Kang H; Global PETTS Investigators, Akksilp R, Sitti W, Wattanaamornkiet W, Andreevskaya SN, Chernousova LN, Demikhova OV, Larionova EE, Smirnova TG, Vasilieva IA, Vorobyeva AV, Barry CE 3rd, Cai Y, Shamputa IC, Bayona J, Contreras C, Bonilla C, Jave O, Brand J, Lancaster J, Odendaal R, Chen MP, Diem L, Metchock B, Tan K, Taylor A, Wolfgang M, Cho E, Eum SY, Kwak HK, Lee J, Lee J, Min S, Degtyareva I, Nemtsova ES, Khorosheva T, Kyryanova EV, Egos G, Perez MT, Tupasi T, Hwang SH, Kim CK, Kim SY, Lee HJ, Kuksa L, Norvaisha I, Skenders G, Sture I, Kummik T, Kuznetsova T, Somova T, Levina K, Pariona G, Yale G, Suarez C, Valencia E, Viiklepp P.

Lancet. 2012 Oct 20;380(9851):1406-17. doi: 10.1016/S0140-6736(12)60734-X. Epub 2012 Aug 30. Erratum in: Lancet. 2012 Oct 20;380(9851):1386.

PMID:
22938757
10.

Effect of exogenous cardiolipin on the growth and viability of Mycobacterium tuberculosis H37Rv in vitro.

Andreevskaya SN, Smirnova TG, Zhogina YA, Smirnova DI, Mikulovich YL, Sorokoumova GM, Chernousova LN, Selishcheva AA, Shvets VI.

Dokl Biol Sci. 2010 Sep-Oct;434:371-4. doi: 10.1134/S0012496610050212. Epub 2010 Oct 21. No abstract available.

PMID:
20963667
11.

Novel pyridazino[4,3-b]indoles with dual inhibitory activity against Mycobacterium tuberculosis and monoamine oxidase.

Velezheva VS, Brennan PJ, Marshakov VY, Gusev DV, Lisichkina IN, Peregudov AS, Tchernousova LN, Smirnova TG, Andreevskaya SN, Medvedev AE.

J Med Chem. 2004 Jun 17;47(13):3455-61.

PMID:
15189042

Supplemental Content

Loading ...
Support Center